During the past decade, Stockholm Center for Eating Disorders conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Stockholm Center for Eating Disorders" are "Binge Eating Disorder" (2 trials). Many other conditions were trialed in "Stockholm Center for Eating Disorders" in a lesser frequency.

Most popular intervention types in "Stockholm Center for Eating Disorders" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Lisdexamfetamine dimesylate" (1 trials) and "SPD489 (Lisdexamfetamine dimesylate)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stockholm Center for Eating Disorders" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Stockholm Center for Eating Disorders". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Stockholm Center for Eating Disorders, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stockholm Center for Eating Disorders, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".